Skip to content
Disclosery

EXANE DERIVATIVES: KO position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on KO, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 54,039 KO shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 54,039 shares
    Change vs previous 13F -2,061 shares

    1.95% of the 13F portfolio, value $3,399,179.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 56,100 shares
    Change vs previous 13F +20,539 shares

    0.98% of the 13F portfolio, value $3,478,224.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 35,561 shares
    Change vs previous 13F -37,960 shares

    0.51% of the 13F portfolio, value $2,105,635.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 73,521 shares
    Change vs previous 13F +26,703 shares

    0.96% of the 13F portfolio, value $3,857,799.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 46,818 shares
    Change vs previous 13F -680 shares

    0.6% of the 13F portfolio, value $2,575,984.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 47,498 shares
    Change vs previous 13F -1,555 shares

    0.75% of the 13F portfolio, value $2,503,735.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 49,053 shares
    Change vs previous 13F +42,576 shares

    0.82% of the 13F portfolio, value $2,690,185.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 6,477 shares
    Change vs previous 13F not available

    0.1% of the 13F portfolio, value $319,778.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).